Abstract
We describe the use of ultrasound-guided high-intensity focused ultrasound (HIFU) for ablation of two pancreatic neuroendocrine tumours (NETs; insulinomas) in two inoperable young female patients. Both suffered from episodes of severe nightly hypoglycemia that was not efficiently controlled by medical treatment. After HIFU ablation, local disease control and symptom relief were achieved without postinterventional complications. The patients remained free of symptoms during 9-month follow-up. The lesions appeared to be decreased in volume, and there was decreased enhancing pattern in the multidetector computed tomography control (MDCT). HIFU is likely to be a valid alternative for symptoms control in patients with pancreatic NETs. However, currently the procedure should be reserved for inoperable patients for whom symptoms cannot be controlled by medical therapy.
This is a preview of subscription content, log in via an institution to check access.
References
Tucker ON, Crotty PL, Conlin KC (2006) The management of insulinoma. Br J Surg 93:264–275
Gill GV, Rauf O, MacFarlane IA (1997) Diazoxide treatment for insulinoma: a national UK survey. Postgrad Med J 73:640–641
Limmer S, Huppert PE, Juette V et al (2009) Radiofrequency ablation of solitary pancreatic insulinoma in a patient with episodes of severe hypoglycemia. Eur J Gastroenterol Hepatol 21:1097–1101
Peppa M, Brountzos E, Economopoulos N et al (2009) Embolization as an alternative treatment of insulinoma in a patient with multiple endocrine neoplasia type 1 syndrome. Cardiovasc Intervent Radiol 32:807–811
Rott G, Biggemann M, Pfohl M (2008) Embolization of an insulinoma of the pancreas with trisacryl gelatin microspheres as definitive treatment. Cardiovasc Intervent Radiol 31:659–662
Wu F, Wang ZB, Zhu H et al (2005) Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: Initial experience. Radiology 236:1034–1040
Oberg K, Eriksson B (2005) Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 19:753–781
Lencioni R, Crocetti L (2005) A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis 9:301–314
Scott A, Hinwood D, Donelly R (2002) Radio-frequency ablation for symptom control in an patient with metastatic pancreatic insulinoma. Clin Endocrinol 56:557–559
Elias D, Baton O, Sideris L et al (2004) Necrotizing pancreatitis after radiofrequency destruction of pancreatic tumours. Eur J Surg Oncol 30:85–87
Matsui Y, Nakagawa A, Kamiyama Y et al (2000) Selective thermocoagulation of unresectable pancreatic cancers by using radiofrequency capacitive heating. Pancreas 20:14–20
Date RS (2006) Current status of local ablative techniques in the treatment of pancreatic cancer. Pancreas 33:198–199
Orgera G, Curigliano G, Krokidis M et al (2010) High-intensity focused ultrasound effect in breast cancer nodal metastasis. Cardiovasc Intervent Radiol 33:447–479
Wu F, Wang ZB, Chen WZ et al (2004) Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma. Ann Surg Oncol 11:1061–1069
Zhang L, Zhu H, Jin C et al (2009) High intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol 19:437–445
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Orgera, G., Krokidis, M., Monfardini, L. et al. High Intensity Focused Ultrasound Ablation of Pancreatic Neuroendocrine Tumours: Report of Two Cases. Cardiovasc Intervent Radiol 34, 419–423 (2011). https://doi.org/10.1007/s00270-010-9884-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-010-9884-0